CrossrefInfokarte
Comparative assessment of efficacy and safety of ambrisentan and bosentan in patients with pulmonary arterial hypertension: A meta‐analysis
Journal of Clinical Pharmacy and Therapeutics · 2022-02 · 47 (2) · 146-156
DOI: 10.1111/jcpt.13481 ↗Abstract
Kein Abstract verfügbar.
EUVIMED